Tembexa

Chimerix, Inc.🇺🇸 United States

FDA Page

Effective Date: Apr 18, 2022
Approval ID: 31d6fa29-791e-4988-8758-e7e4d5b6a352
Products: 1 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TEMBEXA safely and effectively. See full prescribing information for TEMBEXA. TEMBEXA (brincidofovir) tablets, for oral useTEMBEXA (brincidofovir) oral suspensionInitial U.S. Approval: 1996

Quick Stats

Total Products1

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.